Delivery Order SPE2DR25D6028-SPE2DR26FARNH
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively procured and will be performed at the company's corporate office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,650.61 to AmerisourceBergen Drug Corp on November 6, 2025. This firm fixed-price delivery order, issued under a non-competitive set-aside, represents a child action against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,900.41 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order, issued under a non-competitive set-aside arrangement, represents a child contract sourced from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order calls for pharmaceutical products and medical supplies to support federal healthcare operations,...
- The Defense Logistics Agency awarded a delivery order valued at $87,364.19 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 million global pharmaceutical support vehicle running through December 2026. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,211.08 to AmerisourceBergen Drug Corp on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed price delivery order, issued under a non-competitive set-aside designation, represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $45,474.95 to AmerisourceBergen Drug Corp on October 30, 2025, for pharmaceutical products and medical supplies under a firm fixed price contract. This non-competitive delivery order, with an ultimate completion date of October 31, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARNHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,185.24 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price delivery order, designated as a child contract, represents a discrete pharmaceutical or medical supply transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems. The company holds a substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling deliveries across multiple therapeutic domains. This delivery order award reflects the ongoing operational execution of that prime contract vehicle, supporting the Defense Health Agency and other federal healthcare systems' pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/10/25 |